Prone Breast Radiotherapy Treatment Planning Observational Study (HUGProne)
Retrospective Dosimetric Study of Prone Radiotherapy for Breast Cancer
Sponsor: Varian Medical Systems
This observational or N/A phase trial investigates Breast Cancer Female and is currently ongoing. Varian Medical Systems leads this study, which shows 10 recorded versions since 2010 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
10 versions recorded-
Jan 2025 — Present [monthly]
Unknown
Status: Active Not Recruiting → Unknown
-
Sep 2024 — Jan 2025 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
-
Jan 2023 — Jul 2024 [monthly]
Active Not Recruiting
Status: Unknown Status → Active Not Recruiting
-
Jan 2021 — Jan 2023 [monthly]
Unknown Status
▶ Show 5 earlier versions
-
Jun 2019 — Jan 2021 [monthly]
Unknown Status
Status: Active Not Recruiting → Unknown Status
-
Jun 2018 — Jun 2019 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Jul 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
Status: Unknown Status → Active Not Recruiting
-
Jan 2017 — Jul 2017 [monthly]
Unknown Status NA
First recorded
Sep 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Varian Medical Systems
- Vincent Vinh-Hung
For direct contact, visit the study record on ClinicalTrials.gov .